• Who we are
    • About us
    • Our values
    • Environmental, social & governance
    • Therapeutic areas
  • What we do
    • Consulting (Acsel Health)
    • HEOR & market access
    • Scientific communications
    • Patient engagement
  • Insights
  • News & Events
  • Join us
    • Careers
    • Reasons to join
  • Contact us
  • Menu Menu

Publication Library / Publications

Development and validation of a photonumeric scale to assess marionette lines

Background

A validated scale is needed for objective and reproducible comparisons of marionette lines before and after treatment in clinical studies.

Objective

To describe the development and validation of a 5-point photonumeric marionette lines scale.

Methods

The scale was developed to include an assessment guide, verbal descriptors, and real and morphed subject images for each scale grade. Intrarater and interrater reliability was evaluated in initial scale validation (web-based review) (N = 51) and live-subject validation (N = 75) studies, each completed during 2 sessions.

Results

In the initial scale validation study, intrarater agreement for 2 physician raters was near perfect (weighted kappa = 0.92 and 0.94). Interrater agreement was excellent during sessions 1 and 2 (intraclass correlation coefficients of 0.94 and 0.95, respectively). In the live-subject validation study, intrarater agreement for 3 physician raters showed a strong correlation (mean weighted kappa = 0.77). Interrater agreement was high during live-subject validation sessions 1 and 2 (intraclass correlation coefficients = 0.89 for both sessions).

Conclusion

This new marionette lines scale is a validated and reliable scale for physician rating of marionette line severity.

Authors N Kefalas, S R D Cueto, F Urdiales-Gálvez, L Barry, A Gritti, A Marchac, M Lim, C de la Guardia, G Kerson, M Silberberg
Journal Dermatologic Surgery: Official Publication for American Society for Dermatologic Surgery
Therapeutic Area Dermatology
Center of Excellence Patient-Centered outcomes
Year 2023
Read full article

Services

  • Consulting
  • HEOR & market access
  • Scientific communications
  • Creative communications
  • Patient engagement

Company

  • About Us
  • Our values
  • Environmental, social & governance
  • Our commitment to rare disease
  • Careers
  • Reasons to join
  • News & insights
  • Events
  • Locations & contact

Legal and Governance

  • Terms of use
  • Privacy notice
  • Cookie policy
  • IT security measures
  • Modern slavery statement
  • Disclosure UK – ABPI
  • Looking for OpenHealth Company?
  • Legal statements & documents
  • Global ethical business conduct code
  • Suppliers
footer-logo-mark
  • Twitter
  • Linkedin
  • Instagram
  • Facebook

© Copyright OPEN Health 2025. All rights reserved. OPEN Health is a registered trademark.

backtotop-arrow
Scroll to top